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Abstract
Magnetic-guided targeted drug delivery (TDD) systems can enhance the treatment of diverse diseases. Despite the potential and
promising results of nanoparticles, aggregation prevents precise particle guidance in the vasculature. In this study, we developed
a simulation platform to investigate aggregation during steering of nanoparticles using a magnetic field function. The magnetic
field function (MFF) comprises a positive and negative pulsed magnetic field generated by electromagnetic coils, which prevents
adherence of particles to the vessel wall during magnetic guidance. A commonly used Y-shaped vessel was simulated and the
performance of the MFF analyzed; the experimental data were in agreement with the simulation results. Moreover, the effects of
various parameters on magnetic guidance were evaluated and the most influential identified. The simulation results presented herein
will facilitate more precise guidance of nanoparticles in vivo.
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1. Introduction
Micro-nano robotic systems for targeted drug delivery
(TDD) based on non-invasive magnetic force actuation have
been developed for guidance of particles in the vasculature. In
this approach, nanoparticles are injected into a vein and circu-
late in the bloodstream. A magnetic force is used to steer the
particles within the vasculature and guide them to the desired
location. TDD requires generation of the optimal concentration
of particles; i.e., a level greater than the minimum required and
lower than the harmful dose, at the target location in vivo.
In traditional therapeutics, the whole body is exposed to high
concentrations of toxic drugs, which, despite killing cancer
cells, cause severe damage to healthy tissue. This can be over-
come by using specially designed drugs to target only malig-
nant tissues [1, 2]. Although this method has certain benefits,
it is non-optimal since only a tiny fraction of the drug adminis-
tered reaches the target region. Therefore, to enhance treatment
efficacy and maintain the optimal dose at the desired location,
TDD systems have been developed [3].
TDD involves the following two steps: near-target injection
and generation of a high concentration of drug at the site of
interest [4]. However, in many cases, administration of a near-
target injection is medically hazardous. Consequently, guid-
ance of micro-nano carriers within the vasculature requires de-
velopment of a robotic platform.
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Magnetic resonance imaging (MRI)-based systems to steer
microparticles in the vasculature have been described by others
[5, 6]. The requirement for more precise particle steering in the
vasculature led to the development of magnetic-based micro-
robotic platforms [7, 8, 9]. Despite these benefits, however, the
size factor prevents full interactions between particles and cells
and prevents passage of the former through the blood-brain bar-
rier (BBB) for TDD within the brain.
Therefore, we developed a novel nanorobotic platform with
magnetic field function (MFF). The MFF is a simple varying-
direction magnetic gradient used to steer nanoparticles in the
vasculature and overcome the particle–vessel adherence issue.
The details of the system can be found in [10]. Nanoparticles
up to 200 nm can cross the tight endothelial cells of the BBB
[11, 12]. Furthermore, the external magnetic field can improve
transport of magnetic nano particles (MNPs) through cell bar-
rier and BBB by the endocytosis process [13, 14]. Besides, the
evidence of clustered MNPs has been found in the mouse brain
after BBB crossing [14]. Similarly, we also reported that mag-
netic particles of 770 nm (mean diameter) can cross the normal
BBB when subjected to external electromagnetic fields [15].
Despite the encouraging results, in the real world the aggre-
gation phenomenon (which was not considered in the model)
reduces system performance and should be considered during
the design stage of magnetic guidance systems.
The aggregation of microparticles in Y-shaped vessels has
been investigated experimentally [16], and an aggregation sim-
ulation platform has been developed to increase the efficacy of
the magnetic force. To utilize aggregation, it has been sug-
gested that a magnetic force should be applied parallel to the
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direction of blood flow, which results in movement of aggre-
gated particles with blood flow or due to application of a con-
stant magnetic field [17, 18]. Although these studies increased
our understanding of the aggregation phenomenon, aggrega-
tions orthogonal to the direction of flow may result in clogging
of vessel branches, which is clearly not desirable for drug de-
livery to the brain. Moreover, in practice, particle-vessel ad-
herence, which occurs due to low blood-flow velocity near the
vessel walls and could explain the low targeting efficiency upon
application of a constant magnetic gradient is not considered.
Therefore, to both consider the effects of aggregation and
overcome the adherence problem using an MFF, we have de-
veloped a comprehensive platform for simulation of particle
steering. Experimental studies were carried out to verify the
effectiveness of the platform.
In this paper, first, the aggregation in real drug-delivery en-
vironments has been demonstrated and the results of in vivo
experiments are presented. Then, a simulation model of a Y-
shaped channel was developed to investigate the steering per-
formance of aggregated particles under the MFF in the channel;
experimental studies were conducted to verify the results. Fi-
nally, the parameters with the greatest influence on aggregation
were determined to evaluate guidance using the MFF.
2. The magnetic based guidance architecture
To steer magnetic nano particles (MNPs) in the vesicular a
magnetic guidance system which is illustrated in Fig. (1) has
been used. The magnetic force adjusts the particle position and
guides it through the correct outlet.
Electromagnetic actuators generate a force adequate for
nanoparticle steering within the vasculature. The electromag-
netic actuator comprises two sets of coils (7,000 turns and di-
ameter d = 1.0 mm) with a core to increase the magnetic field
density (cobaltiron alloy Vacoflux 50). Currents of up to 17 A
(gradient filed strength 7.9 T/m) can be applied to the system.
The optimum conditions for MFF vary according to blood
vessel size, blood flow velocity, particle size, and the magnetic
field applied. This time varying on-off function changes the
direction of the field function and guides particles to the desired
outlet. The details of MFF are provided elsewhere [10, 15].
2.1. Effects of the aggregation on the targeting performance
The introduced system was used to guide nanoparticles with
350 nm mean diameters to the mouse brain. These fluores-
cent carboxyl magnetic nanocontainers can be used to track the
MNPs in the brain.
The particles were injected into the tail of the mice, which
were then exposed to different magnetic field functions to ex-
perimentally find the optimum condition. To study the drug up-
take, experiments in absence of the magnetic field, with a con-
stant magnetic field and with a magnetic field function (MFF)
have been performed. In absence of the magnetic force no ev-
idence of nanoparticles has been found in the brain. To study
constant magnetic field, the input current increased from 1A to
3A which resulted in higher magnetic force and lead to more
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Figure 1: The mechanism of nanoparticle steering within blood vessels with the
magnetic field function (FF(t)) guidance.
uptake into the brain. With the MFF the rate of particle cross-
ing BBB has been improved significantly. It has been observed
that the MFF could solve the vessel–particle adherence issue
and successfully guided the particles to the cortical areas of the
brain [15].
To study the MFF, the current of the coils has been changed
between 1 to 3 A and the frequency of the magnetic field func-
tion sets as 0.25, 0.5 and 1 Hz. Despite the improvement in the
BBB crossing, we have observed that the particles aggregated
in the brain after crossing BBB as shown in Fig. 2 A and B.
As the aggregation phenomenon was not considered during
the initial design of MFF, it reduced the performance of the
system. The particle distribution analysis indicated that, by us-
ing the optimum conditions in [15], the particle density on the
left and right sides of the brain was almost equal; i.e., the MFF
was ineffective for targeting, even though it helped the magnetic
particles pass through the BBB.
The microscopic image and particle distribution demon-
strates existence of particle aggregation in Fig. 2. Considering
the detrimental effects of aggregation both in BBB crossing and
targeting, the simulation platform should be developed to study
the effects of aggregation. However, the mechanism of BBB
crossing for the aggregated nanoparticles is not in the scope of
this paper and will be studied separately with consideration of
molecular dynamic (MD) based simulations [19]. The simula-
tion platform in this paper has been developed to improve the
steering performance of aggregated MNPs.
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Figure 2: Evidence of aggregation of MNPs after crossing BBB in the left
(A) and right (B) brain hemispheres of a test subject (confocal laser scanning
microscope image), and the particle distribution therein.
3. Dynamic Forces Governing TDD
The major forces governing the aggregation phenomenon
were investigated, an overview of which is provided in this sec-
tion. Many parameters presented in this section will be used
throughout the manuscript and any change in these parameters
will be discussed in subsequent sections. Forces depicted in
Fig. 3 have been taken into account, and the Newtonian dy-
namic model is presented as:
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Figure 3: Free-body diagram of the dominant forces.
mi
dvi
dt
= FMF + Fdrag + Fc + FAd + Fm (1)
where the index i indicates particle i. vi is the particle veloc-
ity, FMF is the magnetic force, Fdrag is the hydrodynamic drag
force, Fm is the gravitational force, Fc is the contact force and
FAd is the adhesion force. To use Newtonian mechanics, parti-
cles are considered to be large enough to exclude the Brownian
effect [18].
The magnetic force is the only actuation source in the
nanorobotic platform. Basically, due to permeability differ-
ences, the nanoparticles are subjected to a force in a magnetic
field [10], which has been modeled as:
FMF = FF(t)[
4
3
piµ1R3Msat∇H] (2)
where Msat is the magnetic polarization, ∇H is the gradient of
magnetic intensity, µ1 is the permeability of the free space and
the particles are considered uniform spheres of radius R. FF(t)
is the time varying function which has been illustrated in the
Fig 1 and used to change the direction of the magnetic field.
Magnetic nanoparticles are super magnets that exhibit
hysteresis-free behavior, which enables them to act as perfect
magnets. During aggregation, the dipole force has two main ef-
fects a negligible contribution to the magnetic intensity (H) and
a major influence on particle-particle adherence after collision.
To model the magnetic moment, a system of coupled equations
must be solved. First, the magnetic intensity for ith particle with
respect to jth is as follows:
Hi j =
µ0
4pi
[3(m j.ri j)ri j)
r5i j
− m j
r3i j
] (3)
where subscripts i and j denote the particles, r is the distance
between the particles and m is the magnetic moment. The total
magnetic intensity for the particle of interest is given as:
H = Hext +
N∑
j
Hdip (4)
where Hext is the external magnetic intensity, and
∑
adds the
accumulated effect of other particles. Finally, the total magnetic
moment can be described as:
Mi =
4pi
µ0
µp − 1
µp + 2
d3i
8
Hi (5)
where µp is the permeability of the particle and d is its diam-
eter. Solving this system of 3N coupled equations yields the
magnetic moment [17, 18].
The drag (hydrodynamic) force of a sphere based on the
Stokes law is:
Fdrag = −6piηR(vp − v f ) (6)
where vp and v f are the particle and fluid velocities, respec-
tively, R is the particle radius and η is the fluid viscosity.
The gravity and bouncy forces determine the gravitational
force, as follows:
Fm =
4
3
piR3(ρp − ρb)G (7)
where R is the particle radius, and ρp and ρb are the particle and
blood densities, respectively.
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Contact forces are generated as a result of particle-particle or
particle-vessel collisions. The Hertzian contact model can be
expressed as:
Fc = kδ
3
2
If↔ d < Ri + R j (8)
where d is the particle-particle distance, Ri is the ith particle
radius, R j is the jth particle radius, k is the spring constant, and
δ is deformation.
Although nanoparticle coating can decrease the effects of ad-
hesion, this force has been introduced since the sticking issue
could not be entirely solved by coating and the parameters of
adhesion model can be adjust based on the coating character-
istics [20]. The adhesion force is a function of the adhesive
energy and deformation area. FAd is modeled as:
FAd = τpi
(3FcR
4E∗
) 2
3 (9)
where τ is the adhesive energy (a constant), R is the equal radius
(R = R1R2R1+R2 ), Fc is the contact force, and E
∗ is the equal elastic-
ity module. The equal elasticity module (E∗) is presented as:
1
E∗
=
1 − υ21
E1
+
1 − υ22
E2
(10)
where the subscripts 1 and 2 denote particle numbers, E is the
elasticity module and υ is Poissons ratio. The opposite nature of
the contact force (separation) and adhesion force (connection)
results in a competition with two possible outcomes; particle
aggregation or particle detachment.
4. Results and Discussion
In this section, a two-dimensional model based on discrete
element method (DEM) simulation for guidance of aggregated
nanoparticles in a Y-shaped blood vessel is described. This sec-
tion is divided into three subsections. In the first, a compu-
tational model capable of generating meaningful physical re-
sults is described. The second subsection compares the simu-
lation results with those obtained experimentally to validate the
accuracy of the model. The final subsection presents particle-
steering performance according to various parameters.
4.1. Aggregation model
Fig. 4 shows a flowchart of the aggregation model. First, the
velocity profile data were extracted using the COMSOL simu-
lation package. Then, the forces were computed based on the
modeling information provided in the previous section. The
contact condition in each time step determined particle integra-
tion, and the magnetic and drag forces governed particle move-
ments. The governing dynamic equation (Eq. 1) at each time
step describes particle position. Following aggregation, the par-
ticles moved at different velocities, so the aggregated particle
velocity was calculated. Based on the field function properties
(Tplus , Tminus) the direction of the magnetic field changed, caus-
ing particle movement within the vessel. Finally, the number of
particles reaching the correct outlet was determined.
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Figure 4: Flowchart of simulation of aggregation in a Y-shaped blood vessel.
4.1.1. Velocity profile within blood vessels
Since blood vessel bifurcations resemble Y-shaped channels,
a Y-shaped channel was used as the model in the simulations.
The Y-shaped channel consists of one inlet and two outlets of
constant diameter dw. A steady creeping flow enters through
the inlet and exits via the outlets. The flow is considered to
be steady state and the CFD module of the COMSOL package
was used to extract the blood velocity profile data based on the
geometry of the vessel.
4.1.2. Simulation of the aggregation
The aggregation phenomenon during MNP magnetic guid-
ance in a Y-shaped channel were simulated, taking into con-
sideration the governing dynamics and using the nominal val-
ues provided in Table (1). The magnetic force (the actuation
force) was simulated based on the model introduced in the pre-
vious section and was considered a body force. In the case of
a particle-particle or particle-vessel contact, the contact and ad-
hesion forces were applied using Eqs. (8) and (9). The drag
force was determined using the blood velocity profile informa-
tion. All of the forces were incorporated into the governing
equation (1) and a system of ODEs was formed.
In this simulation, 225 particles of 400 nm radius were used.
Thus, in each time step, 900 ODE equations must be solved.
Resolution of this ODE system using the RungeKutta method
resulted in identification of the aggregation mechanism (Fig. 5).
The particles aggregated near the inner wall of the vessel in
a parabolic curve shape due to the combined effect of the initial
position of the particles and the blood velocity profile. More-
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Table 1: Parameters used for simulation of TDD.
Category Parameter Value Unit
d 800 (nM)
Particle ρp 6450 (Kg/M3)
Properties Msat 2 (T)
Process ∇H 0.30 (MA/m2)
Environmental ρb 1050 (Kg/M3)
Effects η 0.000894 (Pa.s)
over, particles aggregated in a column shape. There are two
possible scenarios for the particles: if the contact force sur-
passes the total effects of the dipole and adhesion forces, parti-
cles change direction without aggregating; otherwise, they form
a column-shaped assembly.
4.1.3. Guidance of aggregated particles using the MFF
The MFF overcomes the adherence problem and facilitates
particle movement within blood vessels by changing the direc-
tion of the magnetic force. The magnetic and drag forces gov-
ern the dynamics of the movement of particles inside the vessel.
The magnitude of the magnetic and drag forces varies with the
number of aggregated particles in a column. Therefore, particle
velocity varies according to aggregation size. To simulate this
effect, the velocity of each column was computed taking into
consideration the size and number of aggregated particles.
The particles move inside the vessel under the guidance of
the applied MFF and reach the correct outlet. Fig 5 shows the
aggregation simulation within Y-shaped channel. Initially, sin-
gle particles integrate and generate aggregates (t0). Then, the
column-shaped aggregates move based on the designed MFF at
different velocities and reach the bifurcation. Finally, as shown
in Fig 5, particles reach the correct outlet at TFinal. Using this
simulation model, the performance of the MFF can be demon-
strated by computing the number of particles that reach the cor-
rect outlet.
Figure 5: Steering of the aggregated particles in a Y-shaped channel with the
MFF.
4.2. Experimental verification of the computational platform
At the macroscopic level, the magnetic silica particles were
exposed to a magnetic field, and the results demonstrated an
aggregation pattern identical to that suggested by the simula-
tions. At the microscopic level, the particles aggregated in a
column-shaped pattern [18].
To evaluate the accuracy of the simulation model, magnetic
silica particles (800 nm diameter) were guided within a Y-
shaped channel using magnetic actuators. The experimental
setup is shown in Fig. (6).
Figure 6: The Y-shaped channel used in this study.
To precisely steer particles in the channel, we assumed that
the particles that remain in the safe zone (the area between the
upper bound of the vessel and the midpoint of the vessel) reach
the correct outlet (Fig. 5). Therefore, the magnetic force should
be designed in a way that forces particles to remain in the safe
zone. A camera was used to monitor the positions of particles
in the channel. These position data have been used to identify
the time needed for particles to move from vessel boundary to
the safe zone limit.
The magnetic force is a function of the gradient of the mag-
netic intensity (Hg), so we altered Hg and calculated the maxi-
mum time required for particles to reach the safe zone limit; the
results are presented in Fig.(7).
In the computational platform, the time for aggregated par-
ticles to reach the same position in the vessel depends on the
number of aggregated particles. Therefore, simulations using
different numbers of aggregated particles were performed, and
the results are shown in Fig. (7). The simulation results are
in acceptable agreement with those obtained experimentally.
Therefore, the proposed model predicts particle movement pre-
cisely.
4.3. Factors that influence nanoparticle guidance in blood ves-
sels
Since the goal of TDD is to send the maximum number of
particles to the correct outlet, the number of particles reaching
the correct outlet defines the system performance. The efficacy
of the process depends on environmental, geometric and pro-
cess parameters. The parameters with the greatest effects are
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Figure 7: A) Camera data on aggregated particle movement in the safe zone
(MFF Hg = 2.3MA/m2, 0.25 Hz) B) Particle movement in the vessel based
on different magnetic field gradients (Hg) as determined by simulation and ex-
perimentally (the information from Table 1 is used for both experiment and
simulation).
particle size, magnetic intensity gradient and blood-flow veloc-
ity; these were varied within the ranges shown in Table (2).
To evaluate system performance, the relationships between the
various parameters and system performance were determined
by conducting several simulations.
The effects of blood velocity on the percentage of particles
reaching the correct outlet are shown in Fig. (8). The time
required for maximum performance to be achieved decreases
with increasing blood-flow velocity.
Table 2: Parameters found to affect TDD performance.
Range of the parameter change
Hg 0.30 MAm2
vb 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 mms
dp 700, 800, 900, 1000 nm
The magnetic force (the actuation force) is a function of two
parameters: the magnetic intensity gradient and the particle
size. The aggregation influences the magnitude of the mag-
netic force and affects the governing dynamics. Therefore, to
present its effects the force factor [10] is defined as a new pa-
rameter which composed of Hg (magnetic field gradient) and
dp (particle diameter) as R f = Hg.d3p. In the simulation magni-
tude of the magnetic field gradient is considered as a constant
Hg = .307MA/m2 and dp varies according to Table 2. The ge-
ometry of the vessel is considered as vessel diameter dv = 1mm
and vessel length Lv = 10mm and four blood velocity condition
Vb = [100, 25, 10, 2.5] mm/s has been considered. For each
condition, we have performed a simulation and the results have
been illustrated in the Fig. 9.
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Figure 8: Results of simulation of steering performance according to particle
velocity with a MFF duty cycle of 0.25Hz with equal Tplus - Tminus (see Fig. 1)
and Hg = 0.3MA/m2.
The Fig.9 presents the particle distribution pattern. In ab-
sence of the magnetic force, number of particles reaching to the
correct outlet is 50 percent as initially the particles are equally
distributed in the tube. As expected, the magnetic force in-
creased with aggregation so the number of particles reaching
the correct outlet is higher than the previous estimation [10].
In the previous analysis particles considered to be single and
the aggregation effects have not been included so the magnetic
force in the high blood velocity was ineffective as it did not have
enough power to influence. However, the aggregated particles
have a better response with respect to magnetic force.
The Fig.9 C and D presents the particle distribution in the
low flow velocities. In the low velocity the sticking issue of
nanoparticles occurs. The field function concept has been in-
troduced to solve this problem. We have found that the stick-
ing issue has been solved and the evidence of particles have
been found in the mouse brain (details in [15]). The simula-
tion results presented in the Fig.9 C and D confirm that particle
sticking issue has been solved. Nevertheless, the growth in the
number of particles reaching the incorrect outlet is evident. The
main reason for this trend is the increase of magnetic force with
aggregation. The force factor clearly demonstrates this trend as
the growth in the force factor leads to a rise in the number of
particles reaching the incorrect outlet which is the evidence of
the system uncertainty. This analysis is in agreement with our
recent particle distribution analysis experiments (Fig.2).
The aggregation phenomenon also could explain the reason
of the remaining particles increase in the Fig.9 D. The aggrega-
tion leads to a growth in the magnetic force which at the same
time leads to an increase in the vertical velocity of particles.
The rapid vertical movement of particles prevent the particle
movement with the flow (horizontal movement) and results in
a rise in the remaining particles. Consequently, although the
sticking issue has been solved, the particles remain in the ves-
sel as the magnetic force was not adjusted adequately.
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Figure 9: Results of steering performance simulation for a Y-shaped vessel
with dv = 1mm, Lv = 10mm and MFF duty cycle of 0.25Hz with equal Tplus
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5. Conclusion
Although aggregation effectively improves the actuation
force, the phenomenon influences TDD performance markedly.
Therefore, investigation of aggregation can facilitate the im-
provement of targeting efficiency.
The proposed aggregation model simulates steering perfor-
mance in a Y-shaped vessel by means of an MFF, and the results
were in agreement with those obtained experimentally. More-
over, velocity, magnetic intensity and particle size were found
to influence steering efficiency. The results will facilitate design
of a MFF to enable precise guidance of nanoparticles within the
vasculature.
So long as they are retained within the safe zone by the MFF,
particles move rapidly towards the correct outlet. However, the
MFF must be modified to enable precise guidance with respect
to different force factor R f (the particle size and gradient of
magnetic intensity). Moreover, the results of aggregated parti-
cles steering justify the particle distributions in mouse experi-
ments.
Future work will expand the simulations for the multiple
branching and more realistic vessels. Besides, the design of
the field function will be improved to prevent or reduce the ag-
gregation effects.
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